GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (OTCPK:BMYMP.PFD) » Definitions » Revenue

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Revenue

: $45,006.00 Mil (TTM As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Bristol-Myers Squibb Co's revenue for the three months ended in Dec. 2023 was $11,477.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $45,006.00 Mil. Bristol-Myers Squibb Co's Revenue per Share for the three months ended in Dec. 2023 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Warning Sign:

Bristol-Myers Squibb Co revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Bristol-Myers Squibb Co was 0.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Bristol-Myers Squibb Co's highest 3-Year average Revenue per Share Growth Rate was 14.40% per year. The lowest was -8.40% per year. And the median was 4.40% per year.


Bristol-Myers Squibb Co Revenue Historical Data

The historical data trend for Bristol-Myers Squibb Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,145.00 42,518.00 46,385.00 46,159.00 45,006.00

Bristol-Myers Squibb Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,406.00 11,337.00 11,226.00 10,966.00 11,477.00

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Revenue distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Revenue falls into.



Bristol-Myers Squibb Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $45,006.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bristol-Myers Squibb Co  (OTCPK:BMYMP.PFD) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Bristol-Myers Squibb Co Revenue Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.